Eye Itch Relief
NDC 59779-920
Product Information
Eye Itch Relief is a ANDA-approved product labeled by Cvs Pharmacy. This medication is used to prevent and treat itching of the eyes caused by allergies (allergic/seasonal conjunctivitis). It is supplied as a product. This product entry covers the primary NDC 59779-920 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 59779-920?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- KETOTIFEN FUMARATE (UNII: HBD503WORO)
- KETOTIFEN (UNII: X49220T18G) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7)
- GLYCERIN (UNII: PDC6A3C0OX)
- WATER (UNII: 059QF0KO0R)
- HYDROCHLORIC ACID (UNII: QTT17582CB)
- SODIUM HYDROXIDE (UNII: 55X04QC32I)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 311237 - ketotifen 0.025 % Ophthalmic Solution
- RxCUI: 311237 - ketotifen 0.25 MG/ML Ophthalmic Solution
- RxCUI: 311237 - ketotifen 0.025 % (as ketotifen fumarate 0.035 % ) Ophthalmic Solution
- RxCUI: 311237 - ketotifen 0.25 MG/ML (as ketotifen fumarate 0.35 MG/ML) Ophthalmic Solution
* Please review the full disclaimer at the bottom of this page.
Patient Education
Ketotifen Ophthalmic
Ophthalmic ketotifen is used to relieve the itching of allergic pinkeye. Ketotifen is in a class of medications called antihistamines. It works by blocking histamine, a substance in the body that causes allergic symptoms.
[Learn More]
* Please review the full disclaimer at the bottom of this page.